GlaxoSmithKline on FY11 outlook
Hasit Joshipura, MD of GlaxoSmithKline Pharmaceuticals, says the company expects 10-12 per cent growth in the current fiscal coming from almost all verticals. He also sees hospitals segment contributing more to the revenues.
